Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Pseudohypoparathyroidism

1-methyl-3-isobutylxanthine has been researched along with Pseudohypoparathyroidism in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwindinger, WF1
Miric, A1
Zimmerman, D1
Levine, MA1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Pseudohypoparathyroidism

ArticleYear
A novel Gs alpha mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase.
    The Journal of biological chemistry, 1994, Oct-14, Volume: 269, Issue:41

    Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Aluminum; Base Sequence; Child, Preschool; Codon; Co

1994